APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Nuclear Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Therapeutic Nuclear Drug Industry Growth and Trends Forecast to 2032

2 January 2026101 pages

Choose your research edition.

Industry ResearchTherapeutic Nuclear Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Nuclear Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Therapeutic Nuclear Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Nuclear Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Nuclear Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Therapeutic Nuclear Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Therapeutic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Therapeutic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Nuclear Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Therapeutic Nuclear Drug market include Novartis, Dongcheng, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Therapeutic Nuclear Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Nuclear Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Nuclear Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Therapeutic Nuclear Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Therapeutic Nuclear Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Nuclear Drug Market by Company

Novartis

Dongcheng

Bayer

Q BioMed

Mundipharma

Lantheus

Jubilant Radiopharma

International Isotopes

Curium Pharmaceuticals

China Isotope & Radiation

Aurobindo Pharma

Therapeutic Nuclear Drug Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Therapeutic Nuclear Drug Segment by Application

Lymphoma

Thyroid

Bone Metastasis

Other

Therapeutic Nuclear Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Nuclear Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Nuclear Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Nuclear Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Therapeutic Nuclear Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Therapeutic Nuclear Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Therapeutic Nuclear Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Therapeutic Nuclear Drug Market Share by Region (2021-2026) Table 4. Global Therapeutic Nuclear Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Therapeutic Nuclear Drug Market Share by Region (2027-2032) Table 6. Global Therapeutic Nuclear Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Therapeutic Nuclear Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Therapeutic Nuclear Drug Market Size Share by Type (2021-2026) Table 9. Global Therapeutic Nuclear Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Therapeutic Nuclear Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Therapeutic Nuclear Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Therapeutic Nuclear Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Therapeutic Nuclear Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Therapeutic Nuclear Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Therapeutic Nuclear Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Therapeutic Nuclear Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Therapeutic Nuclear Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Therapeutic Nuclear Drug Market Size Share by Application (2021-2026) Table 24. Global Therapeutic Nuclear Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Therapeutic Nuclear Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Therapeutic Nuclear Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Therapeutic Nuclear Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Therapeutic Nuclear Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Therapeutic Nuclear Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Therapeutic Nuclear Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Therapeutic Nuclear Drug Industry Trends Table 37. Therapeutic Nuclear Drug Industry Drivers Table 38. Therapeutic Nuclear Drug Industry Opportunities and Challenges Table 39. Therapeutic Nuclear Drug Industry Restraints Table 40. Global Therapeutic Nuclear Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Therapeutic Nuclear Drug Revenue Market Share by Company (2021-2026) Table 42. Global Therapeutic Nuclear Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Therapeutic Nuclear Drug Key Company Headquarters & Area Served Table 44. Global Therapeutic Nuclear Drug Company, Product Type & Application Table 45. Global Therapeutic Nuclear Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Therapeutic Nuclear Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis Company Information Table 49. Novartis Business Overview Table 50. Novartis Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis Therapeutic Nuclear Drug Product Portfolio Table 52. Novartis Recent Development Table 53. Dongcheng Company Information Table 54. Dongcheng Business Overview Table 55. Dongcheng Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Dongcheng Therapeutic Nuclear Drug Product Portfolio Table 57. Dongcheng Recent Development Table 58. Bayer Company Information Table 59. Bayer Business Overview Table 60. Bayer Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bayer Therapeutic Nuclear Drug Product Portfolio Table 62. Bayer Recent Development Table 63. Q BioMed Company Information Table 64. Q BioMed Business Overview Table 65. Q BioMed Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Q BioMed Therapeutic Nuclear Drug Product Portfolio Table 67. Q BioMed Recent Development Table 68. Mundipharma Company Information Table 69. Mundipharma Business Overview Table 70. Mundipharma Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Mundipharma Therapeutic Nuclear Drug Product Portfolio Table 72. Mundipharma Recent Development Table 73. Lantheus Company Information Table 74. Lantheus Business Overview Table 75. Lantheus Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Lantheus Therapeutic Nuclear Drug Product Portfolio Table 77. Lantheus Recent Development Table 78. Jubilant Radiopharma Company Information Table 79. Jubilant Radiopharma Business Overview Table 80. Jubilant Radiopharma Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Jubilant Radiopharma Therapeutic Nuclear Drug Product Portfolio Table 82. Jubilant Radiopharma Recent Development Table 83. International Isotopes Company Information Table 84. International Isotopes Business Overview Table 85. International Isotopes Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. International Isotopes Therapeutic Nuclear Drug Product Portfolio Table 87. International Isotopes Recent Development Table 88. Curium Pharmaceuticals Company Information Table 89. Curium Pharmaceuticals Business Overview Table 90. Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Curium Pharmaceuticals Therapeutic Nuclear Drug Product Portfolio Table 92. Curium Pharmaceuticals Recent Development Table 93. China Isotope & Radiation Company Information Table 94. China Isotope & Radiation Business Overview Table 95. China Isotope & Radiation Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. China Isotope & Radiation Therapeutic Nuclear Drug Product Portfolio Table 97. China Isotope & Radiation Recent Development Table 98. Aurobindo Pharma Company Information Table 99. Aurobindo Pharma Business Overview Table 100. Aurobindo Pharma Therapeutic Nuclear Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Aurobindo Pharma Therapeutic Nuclear Drug Product Portfolio Table 102. Aurobindo Pharma Recent Development Table 103. North America Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Therapeutic Nuclear Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Therapeutic Nuclear Drug Market Share by Country (2021-2026) Table 106. North America Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Therapeutic Nuclear Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Therapeutic Nuclear Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Therapeutic Nuclear Drug Market Share by Country (2021-2026) Table 111. Europe Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Therapeutic Nuclear Drug Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Therapeutic Nuclear Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Therapeutic Nuclear Drug Market Share by Country (2021-2026) Table 116. Asia-Pacific Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Therapeutic Nuclear Drug Market Share Forecast by Country (2027-2032) Table 118. Latin America Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Therapeutic Nuclear Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Therapeutic Nuclear Drug Market Share by Country (2021-2026) Table 121. Latin America Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Therapeutic Nuclear Drug Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Therapeutic Nuclear Drug Market Share by Country (2021-2026) Table 126. Middle East & Africa Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Therapeutic Nuclear Drug Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Therapeutic Nuclear Drug Product Image Figure 3. Global Therapeutic Nuclear Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Therapeutic Nuclear Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Therapeutic Nuclear Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Therapeutic Nuclear Drug Market Share by Region (2021-2032) Figure 7. North America Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Lutetium-177 Image Figure 13. Global Lutetium-177 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Radium-223 Image Figure 15. Global Radium-223 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Iodine-131 Image Figure 17. Global Iodine-131 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Therapeutic Nuclear Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Therapeutic Nuclear Drug Market Share by Type 2025 VS 2032 Figure 22. North America Therapeutic Nuclear Drug Market Size Share by Type (2021-2032) Figure 23. Europe Therapeutic Nuclear Drug Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Therapeutic Nuclear Drug Market Size Share by Type (2021-2032) Figure 25. Latin America Therapeutic Nuclear Drug Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Therapeutic Nuclear Drug Market Size Share by Type (2021-2032) Figure 27. Lymphoma Image Figure 28. Global Lymphoma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Thyroid Image Figure 30. Global Thyroid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Bone Metastasis Image Figure 32. Global Bone Metastasis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Other Image Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Therapeutic Nuclear Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Therapeutic Nuclear Drug Market Share by Application 2025 VS 2032 Figure 37. North America Therapeutic Nuclear Drug Market Size Share by Application (2021-2032) Figure 38. Europe Therapeutic Nuclear Drug Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Therapeutic Nuclear Drug Market Size Share by Application (2021-2032) Figure 40. Latin America Therapeutic Nuclear Drug Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Therapeutic Nuclear Drug Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Therapeutic Nuclear Drug Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Therapeutic Nuclear Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Therapeutic Nuclear Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 47. Europe Therapeutic Nuclear Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Therapeutic Nuclear Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 50. Asia-Pacific Therapeutic Nuclear Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Therapeutic Nuclear Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 53. Latin America Therapeutic Nuclear Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Therapeutic Nuclear Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 56. Middle East & Africa Therapeutic Nuclear Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Therapeutic Nuclear Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Therapeutic Nuclear Drug Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Lymphoma
  • Thyroid
  • Bone Metastasis
  • Other
Companies covered
  • Novartis
  • Dongcheng
  • Bayer
  • Q BioMed
  • Mundipharma
  • Lantheus
  • Jubilant Radiopharma
  • International Isotopes
  • Curium Pharmaceuticals
  • China Isotope & Radiation
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Therapeutic Nuclear Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Therapeutic Nuclear Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Therapeutic Nuclear Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Therapeutic Nuclear Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Therapeutic Nuclear Drug Market Size (2021-2032)
  8. 1.5.1 North America Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Therapeutic Nuclear Drug Market Size Growth Rate (2021-2032)
2 Therapeutic Nuclear Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Lutetium-177
  3. 2.1.2 Radium-223
  4. 2.1.3 Iodine-131
  5. 2.1.4 Other
  6. 2.2 Global Therapeutic Nuclear Drug Market Size by Type
  7. 2.2.1 Global Therapeutic Nuclear Drug Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Therapeutic Nuclear Drug Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Therapeutic Nuclear Drug Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Therapeutic Nuclear Drug Market Size by Regions
  11. 2.3.1 North America Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Therapeutic Nuclear Drug Market Size Breakdown by Type (2021-2026)
3 Therapeutic Nuclear Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Lymphoma
  3. 3.1.2 Thyroid
  4. 3.1.3 Bone Metastasis
  5. 3.1.4 Other
  6. 3.2 Global Therapeutic Nuclear Drug Market Size by Application
  7. 3.2.1 Global Therapeutic Nuclear Drug Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Therapeutic Nuclear Drug Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Therapeutic Nuclear Drug Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Therapeutic Nuclear Drug Market Size by Regions
  11. 3.3.1 North America Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Therapeutic Nuclear Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Therapeutic Nuclear Drug Industry Trends
  2. 4.2 Therapeutic Nuclear Drug Industry Drivers
  3. 4.3 Therapeutic Nuclear Drug Industry Opportunities and Challenges
  4. 4.4 Therapeutic Nuclear Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Therapeutic Nuclear Drug Revenue (2021-2026)
  2. 5.2 Global Therapeutic Nuclear Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Therapeutic Nuclear Drug Key Company Headquarters & Area Served
  4. 5.4 Global Therapeutic Nuclear Drug Company, Product Type & Application
  5. 5.5 Global Therapeutic Nuclear Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Therapeutic Nuclear Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Therapeutic Nuclear Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Therapeutic Nuclear Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Therapeutic Nuclear Drug Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Dongcheng
  8. 6.2.1 Dongcheng Company Information
  9. 6.2.2 Dongcheng Business Overview
  10. 6.2.3 Dongcheng Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Dongcheng Therapeutic Nuclear Drug Product Portfolio
  12. 6.2.5 Dongcheng Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Therapeutic Nuclear Drug Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Q BioMed
  20. 6.4.1 Q BioMed Company Information
  21. 6.4.2 Q BioMed Business Overview
  22. 6.4.3 Q BioMed Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Q BioMed Therapeutic Nuclear Drug Product Portfolio
  24. 6.4.5 Q BioMed Recent Developments
  25. 6.5 Mundipharma
  26. 6.5.1 Mundipharma Company Information
  27. 6.5.2 Mundipharma Business Overview
  28. 6.5.3 Mundipharma Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Mundipharma Therapeutic Nuclear Drug Product Portfolio
  30. 6.5.5 Mundipharma Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Lantheus Therapeutic Nuclear Drug Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 Jubilant Radiopharma
  38. 6.7.1 Jubilant Radiopharma Company Information
  39. 6.7.2 Jubilant Radiopharma Business Overview
  40. 6.7.3 Jubilant Radiopharma Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Jubilant Radiopharma Therapeutic Nuclear Drug Product Portfolio
  42. 6.7.5 Jubilant Radiopharma Recent Developments
  43. 6.8 International Isotopes
  44. 6.8.1 International Isotopes Company Information
  45. 6.8.2 International Isotopes Business Overview
  46. 6.8.3 International Isotopes Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 International Isotopes Therapeutic Nuclear Drug Product Portfolio
  48. 6.8.5 International Isotopes Recent Developments
  49. 6.9 Curium Pharmaceuticals
  50. 6.9.1 Curium Pharmaceuticals Company Information
  51. 6.9.2 Curium Pharmaceuticals Business Overview
  52. 6.9.3 Curium Pharmaceuticals Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Curium Pharmaceuticals Therapeutic Nuclear Drug Product Portfolio
  54. 6.9.5 Curium Pharmaceuticals Recent Developments
  55. 6.10 China Isotope & Radiation
  56. 6.10.1 China Isotope & Radiation Company Information
  57. 6.10.2 China Isotope & Radiation Business Overview
  58. 6.10.3 China Isotope & Radiation Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 China Isotope & Radiation Therapeutic Nuclear Drug Product Portfolio
  60. 6.10.5 China Isotope & Radiation Recent Developments
  61. 6.11 Aurobindo Pharma
  62. 6.11.1 Aurobindo Pharma Company Information
  63. 6.11.2 Aurobindo Pharma Business Overview
  64. 6.11.3 Aurobindo Pharma Therapeutic Nuclear Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Aurobindo Pharma Therapeutic Nuclear Drug Product Portfolio
  66. 6.11.5 Aurobindo Pharma Recent Developments
7 North America
  1. 7.1 North America Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  3. 7.3 North America Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  3. 10.3 South America Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Therapeutic Nuclear Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Therapeutic Nuclear Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Therapeutic Nuclear Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst